Premium
Resecting hepatocellular carcinoma in cirrhotic liver
Author(s) -
FAN SHEUNG TAT
Publication year - 2004
Publication title -
journal of gastroenterology and hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.214
H-Index - 130
eISSN - 1440-1746
pISSN - 0815-9319
DOI - 10.1111/j.1440-1746.2004.03716.x
Subject(s) - medicine , hepatocellular carcinoma , indocyanine green , resection , cirrhosis , blood loss , gastroenterology , carcinoma , chronic hepatitis , hepatectomy , hepatitis , surgery , radiology , virus , virology
Resecting hepatocellular carcinoma (HCC) in a cirrhotic patient is potentially dangerous and recurrence of HCC after operation is high. Our current strategy consists of careful preoperative assessment of liver functions by indocyanine green clearance test, intraoperative techniques to reduce blood loss, and postoperative surveillance and prompt treatment of recurrences. The 5‐year overall survival rate of HCC patients after resection is 34.3%, which is comparable with that in patients with normal liver (37.3%) or chronic hepatitis (45.3%).